文献速递神经MR

扩散与灌注MRI可能预测IDH野生型低级别胶质瘤的EGFR扩增和TERT启动子突变状态

Diffusion and perfusion MRI may predict EGFR amplification and the TERT promoter mutation status of IDH-wildtype lower-grade gliomas.
PubMed 文献 · Eur Radiol · 2020-08-12

本研究纳入49例IDH野生型低级别胶质瘤患者,评估扩散张量成像和灌注MRI参数能否预测EGFR扩增和TERTp突变状态。结果显示EGFR扩增组平均ADC值较低(p=0.019),ADC是独立预测因子(AUC=0.75);TERTp突变组平均nCBV、nCBF和Vp较高,Vp是独立预测因子(AUC=0.85)。作者认为较低ADC值可能有助于预测EGFR扩增,较高Vp值可能有助于预测TERTp突变状态。

要点

  • IDH野生型低级别胶质瘤中,EGFR扩增组平均ADC值低于非扩增组(p=0.019),ADC是EGFR扩增的独立预测因子(AUC=0.75)。
  • TERTp突变组平均nCBV(p=0.020)、nCBF(p=0.017)和Vp(p=0.002)均高于野生型组,Vp是TERTp突变的独立预测因子(AUC=0.85)。
  • 作者认为较低ADC值可能提示EGFR扩增(细胞密度较高),较高Vp值可能提示TERTp突变(血管增生和肿瘤血管生成)。

核心结论

  • 这项探索性先导研究显示,较低ADC值可能有助于预测IDH野生型低级别胶质瘤的EGFR扩增,较高Vp值可能有助于预测其TERTp突变状态。

研究设计与样本

  • 探索性先导研究,共纳入49例IDH野生型低级别胶质瘤患者(WHO II/III级),其中EGFR扩增状态已知者39例非扩增、10例扩增,TERTp突变状态已知者19例野生型、21例突变型,均行MRI检查(包括扩散张量成像和动态磁敏感对比灌注成像、动态对比增强成像)。

关键影像表现/征象

  • EGFR扩增组平均ADC值低于EGFR非扩增组(p=0.019),作者认为这提示细胞密度较高。
  • TERTp突变组平均nCBV高于TERTp野生型组(p=0.020)。
  • TERTp突变组平均nCBF高于TERTp野生型组(p=0.017)。
  • TERTp突变组平均Vp高于TERTp野生型组(p=0.002),作者认为这提示血管增生和肿瘤血管生成较高。

诊断标准与关键数值

  • 平均ADC为EGFR扩增的独立预测因子,AUC为0.75。
  • 平均Vp为TERTp突变状态的独立预测因子,AUC为0.85。

临床应用与阅片要点

  • 作者认为较低ADC值可能有助于预测IDH野生型低级别胶质瘤的EGFR扩增。
  • 作者认为较高Vp值可能有助于预测IDH野生型低级别胶质瘤的TERTp突变状态。

局限性

  • 原文称本研究为探索性先导研究(exploratory pilot study)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: Epidermal growth factor receptor (EGFR) amplification and telomerase reverse transcriptase promoter (TERTp) mutation status of isocitrate dehydrogenase-wildtype (IDHwt) lower-grade gliomas (LGGs; grade II/III) are crucial for identifying IDHwt LGG with an aggressive clinical course. The purpose of this study was to assess whether parameters from diffusion tensor imaging, dynamic susceptibility contrast (DSC), and diffusion tensor imaging, dynamic contrast-enhanced imaging can predict the EGFR amplification and TERTp mutation status of IDHwt LGGs.

METHODS: A total of 49 patients with IDHwt LGGs with either known EGFR amplification (39 non-amplified, 10 amplified) or TERTp mutation (19 wildtype, 21 mutant) statuses underwent MRI. The mean ADC, fractional anisotropy (FA), normalized cerebral blood volume (nCBV), normalized cerebral blood flow (nCBF), volume transfer constant (Ktrans), rate transfer coefficient (Kep), extravascular extracellular volume fraction (Ve), and plasma volume fraction (Vp) values were assessed. Univariate and multivariate logistic regression models were constructed.

RESULTS: EGFR-amplified tumors showed lower mean ADC values than EGFR-non-amplified tumors (p = 0.019). Mean ADC was an independent predictor of EGFR amplification, with an AUC of 0.75. TERTp mutant tumors showed higher mean nCBV (p = 0.020), higher mean nCBF (p = 0.017), and higher mean Vp (p = 0.002) than TERTp wildtype tumors. With multivariate logistic regression, mean Vp was the independent predictor of TERTp mutation status, with an AUC of 0.85.

CONCLUSION: This exploratory pilot study shows that lower ADC values may be useful for prediction of EGFR amplification, whereas higher Vp values may be useful for prediction of the TERTp mutation status of IDHwt LGGs.

KEY POINTS: • EGFR amplification and TERTp mutation are key molecular markers that predict an aggressive clinical course of IDHwt LGGs. • EGFR-amplified tumors showed lower ADC values than EGFR-non-amplified tumors, suggesting higher cellularity. • TERTp mutant tumors showed a higher plasma volume fraction than TERTp wildtype tumors, suggesting higher vascular proliferation and tumor angiogenesis.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Park YW, Ahn SS, Park CJ, et al. Diffusion and perfusion MRI may predict EGFR amplification and the TERT promoter mutation status of IDH-wildtype lower-grade gliomas. Eur Radiol. 2020. PMID: 32785770. doi:10.1007/s00330-020-07090-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。